Protara Therapeutics Inc. (TARA)
$3.95
$0.05
(1.28%)
As on 02-Sep-2026 14:34EDT
Market cap
$226 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
1.5
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.5 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0.7
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-1.4
-
Face value
--
-
Shares outstanding
59,095,488
10 Years Aggregate
CFO
$-234.40 Mln
EBITDA
$-255.84 Mln
Net Profit
$-309.26 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Protara Therapeutics (TARA)
| -25.9 | 0.8 | -12.6 | 26.6 | 21.9 | -13.6 | -36.1 |
|
BSE Sensex
| -9.6 | -2.0 | 3.1 | -4.7 | 5.4 | 6.0 | 10.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Protara Therapeutics (TARA)
| 0.9 | 179.2 | -30.0 | -60.3 | -72.1 | 47.6 | -81.9 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Protara Therapeutics (TARA)
|
4.0 | 225.7 | 0.0 | -70.0 | -- | -39.1 | -- | 1.5 |
| 84.3 | 11,993.9 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.9 | |
| 265.6 | 16,261.1 | 1,054.4 | 755.9 | 5.7 | -- | 19 | 9.8 | |
| 71.2 | 10,022.2 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.3 | |
| 58.4 | 13,491.7 | 2,435.9 | 860.6 | 31.0 | 43 | 17.4 | 7.4 | |
| 109.2 | 11,957.0 | 1,663.7 | 413.6 | 36.3 | 430 | 30.9 | 84.5 | |
| 366.5 | 10,402.8 | 440.5 | 241.5 | 33.4 | 18.7 | 44.1 | 7.8 | |
| 543.3 | 12,332.1 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 24.0 | |
| 592.3 | 16,765.1 | 2,782.3 | 491.5 | 21.1 | 110.1 | 35.2 | 39.3 | |
| 357.4 | 9,625.4 | 0.0 | -339.1 | -- | -30.6 | -- | 7.6 |
Shareholding Pattern
View DetailsAbout Protara Therapeutics (TARA)
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, which is in... Phase II clinical trial for the treatment of non-muscle invasive bladder cancer and lymphatic malformations. It is also developing intravenous choline chloride, an investigational phospholipid substrate replacement therapy for patients receiving parenteral nutrition and fluids. The company is headquartered in New York, New York. Read more
-
Co-Founder, CEO, President & Director
Mr. Jesse Shefferman
-
Co-Founder, CEO, President & Director
Mr. Jesse Shefferman
-
Headquarters
New York, NY
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Protara Therapeutics (TARA)
What is the current share price of Protara Therapeutics Inc (TARA) Today?
The share price of Protara Therapeutics Inc (TARA) is $3.95 (NASDAQ) as of 02-Sep-2026 14:34 EDT. Protara Therapeutics Inc (TARA) has given a return of 21.91% in the last 3 years.
What is the current PB & PE ratio of Protara Therapeutics Inc (TARA)?
Since, TTM earnings of Protara Therapeutics Inc (TARA) is negative, P/E ratio is not available.
The P/B ratio of Protara Therapeutics Inc (TARA) is 1.47 times as on 28-Aug-2026, a 72 discount to its peers’ median range of 5.18 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-4.27 |
1.25 |
2024 |
-3.13 |
0.84 |
2023 |
-0.53 |
0.31 |
2022 |
-0.46 |
0.30 |
2021 |
-1.61 |
0.47 |
What is the 52 Week High and Low of Protara Therapeutics Inc (TARA)?
The 52-week high and low of Protara Therapeutics Inc (TARA) are Rs 7.82 and Rs 3.02 as of 03-Sep-2026.
What is the market cap of Protara Therapeutics Inc (TARA)?
Protara Therapeutics Inc (TARA) has a market capitalisation of $ 226 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Protara Therapeutics Inc (TARA)?
Before investing in Protara Therapeutics Inc (TARA), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.